ÂÜÀòÂÒÂ×

Stephen DiMagno is an accomplished professional in the field of chemistry with extensive experience in academic and entrepreneurial settings. Since October 2021, Stephen has served as the Head of Discovery Research and Senior Vice President of Chemistry at Ratio Therapeutics. As the Founder and Scientific Advisor of Ground Fluor Pharmaceuticals, Inc. since March 2012, Stephen has been involved in developing 18F-labeled radiotracers for PET imaging utilizing technology licensed from the University of Nebraska. Stephen has also operated as a Discovery Chemistry and Manufacturing Consultant since January 2012 and held a professorship in the Department of Medicinal Chemistry & Pharmacognosy at the University of Illinois at Chicago until November 2021. Prior roles include Professor of Chemistry at the University of Nebraska-Lincoln and Chair of the ACS Division of Fluorine Chemistry. Stephen earned a PhD in Chemistry from the University of California, Berkeley, and a BA in Chemistry from Swarthmore College.